Professor Eli Schwartz – founder of the Center for Travel Medicine and Tropical Disease at Sheba – joins the ranks of other physicians who say that Ivermectin is an effective treatment for Covid-19. A number of groups of physicians have promoted Ivermectin as an inexpensive and effective treatment for Covid-19, particularly when prescribed early.
According to The Jerusalem Post, Schwartz “conducted a randomized, controlled, double-blinded trial from May 15, 2020, through the end of January 2021 to evaluate the effectiveness of ivermectin in reducing viral shedding among nonhospitalized patients with mild to moderate COVID-19.”
The drug is also extremely economical. A study published in the peer-reviewed American Journal of Therapeutics showed that the cost of ivermectin for other treatments in Bangladesh is around $0.60 to $1.80 for a five-day course. It costs up to $10 a day in Israel, Schwartz said.
The FLCCC – an alliance of physicians and researchers – developed a protocol to treat Covid-19 using Ivermectin in 2020. The FLCCC has been very critical of the U.S. CDC and The World Health Organization (WHO) for downplaying the effectiveness of Ivermectin in treating Covid.
“I am deeply troubled that the WHO made this hasty decision on guidance before reviewing all available data,” said Pierre Kory, MD, MPH, president and chief medical officer of the FLCCC. “Their recommendation ignores the evidence, creates more controversy, and will only lead to continuing suffering and death from COVID-19. There are now over 24 randomized trials results that have been reported to the Unitaid/WHO team yet todays guidance was inexcusably based on a faulty analysis of just 16 of the available trials. Further, these erroneous findings directly conflict with numerous other peer-reviewed expert analyses that have found the data overwhelmingly demonstrates that ivermectin saves lives from COVID-19. There is no reason not to recommend it for everyone as a safe drug for prevention and treatment.”
